Cargando…

External validation of Villalta score in high-middle income country patients with deep vein thrombosis

Post-thrombotic syndrome (PTS) is a late complication that does not have a cure yet, with a prevalence estimated between 20 to 75%, associated with previous deep vein thrombosis event. Although the Villalta score (VS) is the gold-standard clinical tool for diagnostic and prognostic evaluation of PTS...

Descripción completa

Detalles Bibliográficos
Autores principales: de Ávila, Rafael Bernardes, Marcondes, Giulianna Barreira, Dias, Silfayner Victor Mathias, da Silveira, Beatriz Périco, de Amorim, Jorge Eduardo, Neto, Henrique Jorge Guedes, Nakano, Luis Carlos Uta, Flumignan, Ronald Luiz Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276430/
https://www.ncbi.nlm.nih.gov/pubmed/35713439
http://dx.doi.org/10.1097/MD.0000000000029367
_version_ 1784745725683302400
author de Ávila, Rafael Bernardes
Marcondes, Giulianna Barreira
Dias, Silfayner Victor Mathias
da Silveira, Beatriz Périco
de Amorim, Jorge Eduardo
Neto, Henrique Jorge Guedes
Nakano, Luis Carlos Uta
Flumignan, Ronald Luiz Gomes
author_facet de Ávila, Rafael Bernardes
Marcondes, Giulianna Barreira
Dias, Silfayner Victor Mathias
da Silveira, Beatriz Périco
de Amorim, Jorge Eduardo
Neto, Henrique Jorge Guedes
Nakano, Luis Carlos Uta
Flumignan, Ronald Luiz Gomes
author_sort de Ávila, Rafael Bernardes
collection PubMed
description Post-thrombotic syndrome (PTS) is a late complication that does not have a cure yet, with a prevalence estimated between 20 to 75%, associated with previous deep vein thrombosis event. Although the Villalta score (VS) is the gold-standard clinical tool for diagnostic and prognostic evaluation of PTS, there are currently no VS intra-rater agreement established and no validation studies for VS’ application into Brazilian Portuguese. We sought to translate and validate VS reliability systematically; and, secondarily, to compare the ultrasound findings with the severity of PTS. We systematically translated the original VS into Brazilian Portuguese (BP). Fifty participants who underwent two outpatient visits were evaluated using the translated VS. We assessed its intra-rater and inter-rater agreement and compared BP VS versus CEAP clinical component (CEAP C), and the clinical PTS severity versus the duplex ultrasound (DUS) findings. The study and its report followed the Guidelines for Reporting Reliability and Agreement Studies. The intra-rater evaluation of VS grades had a simple Kappa coefficient of 0.73, and the simple Kappa coefficient inter-rater for VS grades was 0.67. When VS was compared to CEAP C, it established a remarkably high correlation over 0.9. There was difference among VS values compared to DUS initial deep vein thrombosis territory, with femoropopliteal showing higher values than distal veins. Higher VS values were correlated to DUS venous recanalization and reflux. There was a substantial inter-rater and intra-rater agreement when the BP VS was applied; and when compared to CEAP C, VS showed a high correlation. When VS grading was compared to DUS characteristics, there were significant statistical and clinical correlation, with presence of reflux and recanalization showing higher VS values. This external VS validation also changes the clinical practice allowing the VS use in a different population and establishes the VS intra-rater agreement.
format Online
Article
Text
id pubmed-9276430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92764302022-08-01 External validation of Villalta score in high-middle income country patients with deep vein thrombosis de Ávila, Rafael Bernardes Marcondes, Giulianna Barreira Dias, Silfayner Victor Mathias da Silveira, Beatriz Périco de Amorim, Jorge Eduardo Neto, Henrique Jorge Guedes Nakano, Luis Carlos Uta Flumignan, Ronald Luiz Gomes Medicine (Baltimore) 3400 Post-thrombotic syndrome (PTS) is a late complication that does not have a cure yet, with a prevalence estimated between 20 to 75%, associated with previous deep vein thrombosis event. Although the Villalta score (VS) is the gold-standard clinical tool for diagnostic and prognostic evaluation of PTS, there are currently no VS intra-rater agreement established and no validation studies for VS’ application into Brazilian Portuguese. We sought to translate and validate VS reliability systematically; and, secondarily, to compare the ultrasound findings with the severity of PTS. We systematically translated the original VS into Brazilian Portuguese (BP). Fifty participants who underwent two outpatient visits were evaluated using the translated VS. We assessed its intra-rater and inter-rater agreement and compared BP VS versus CEAP clinical component (CEAP C), and the clinical PTS severity versus the duplex ultrasound (DUS) findings. The study and its report followed the Guidelines for Reporting Reliability and Agreement Studies. The intra-rater evaluation of VS grades had a simple Kappa coefficient of 0.73, and the simple Kappa coefficient inter-rater for VS grades was 0.67. When VS was compared to CEAP C, it established a remarkably high correlation over 0.9. There was difference among VS values compared to DUS initial deep vein thrombosis territory, with femoropopliteal showing higher values than distal veins. Higher VS values were correlated to DUS venous recanalization and reflux. There was a substantial inter-rater and intra-rater agreement when the BP VS was applied; and when compared to CEAP C, VS showed a high correlation. When VS grading was compared to DUS characteristics, there were significant statistical and clinical correlation, with presence of reflux and recanalization showing higher VS values. This external VS validation also changes the clinical practice allowing the VS use in a different population and establishes the VS intra-rater agreement. Lippincott Williams & Wilkins 2022-06-17 /pmc/articles/PMC9276430/ /pubmed/35713439 http://dx.doi.org/10.1097/MD.0000000000029367 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 3400
de Ávila, Rafael Bernardes
Marcondes, Giulianna Barreira
Dias, Silfayner Victor Mathias
da Silveira, Beatriz Périco
de Amorim, Jorge Eduardo
Neto, Henrique Jorge Guedes
Nakano, Luis Carlos Uta
Flumignan, Ronald Luiz Gomes
External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title_full External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title_fullStr External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title_full_unstemmed External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title_short External validation of Villalta score in high-middle income country patients with deep vein thrombosis
title_sort external validation of villalta score in high-middle income country patients with deep vein thrombosis
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276430/
https://www.ncbi.nlm.nih.gov/pubmed/35713439
http://dx.doi.org/10.1097/MD.0000000000029367
work_keys_str_mv AT deavilarafaelbernardes externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT marcondesgiuliannabarreira externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT diassilfaynervictormathias externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT dasilveirabeatrizperico externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT deamorimjorgeeduardo externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT netohenriquejorgeguedes externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT nakanoluiscarlosuta externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis
AT flumignanronaldluizgomes externalvalidationofvillaltascoreinhighmiddleincomecountrypatientswithdeepveinthrombosis